“…Additionally, 3,5-DiCQA and other chlorogenic acids have been associated to anti-virus-cell fusion properties against numerous human viruses like human immunodeficiency virus, influenza A, herpes simplex 1 and 2, Coxsackie B3, adenovirus and respiratory syncytial viruses [17][18][19] . In parallel to these anti-viral activities, 3,5-DiCQA has also been assigned as a potent antiinflammatory compound against lipopolysaccharide-induced acute lung injury through the inhibition of human neutrophil elastase activity, making it a potential new therapeutic candidate against acute viral pneumonia diseases 20,21 . Finally, 3,5-DiCQA has also been identified as a hypotensive molecule, inhibiting angiotensin Iconverting enzyme (ACE) 22,23 .…”